InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Palmer Ashleigh, 董事长兼首席执行官. Director active across 1 company, notably Provention Bio, Inc.. In total, 4 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €22k. Activity tracked since 30 November 2021. The latest transaction was filed on 10 February 2023 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Ashleigh Palmer is the Director and CEO of Provention Bio, Inc. She leads the company by defining its strategic vision and overseeing its operations. Her expertise in the biopharmaceutical field enables her to guide Provention Bio towards cutting-edge innovations and therapeutic solutions.